EADV 2026: Advances in Diagnosis and Assessment of Lupus Erythematosus
LUPUS ERYTHEMATOSUS (LE) is an autoimmune connective tissue disease with a wide range of skin (cutaneous lupus erythematosus [CLE]) and/or systemic (systemic lupus erythematosus [SLE]) manifestations.Cutaneous involvement is found in up to 80% of patients with SLE,1 and CLE is observed as an initial manifestation of SLE in 0-42% of cases.2LE skin changes are divided into LEspecific (acute CLE, subacute CLE, chronic CLE) and LE-nonspecific (vascular and nonvascular signs) subtypes.3Some of these are more likely to lead to scarring (chronic CLE), but others have a higher risk of progression to SLE (acute CLE, subacute CLE).4
Authors
- Guleva
Institutions
- Military Medical Academy (BG)
Publication Details
- Journal
- EMJ Dermatology
- Published
- 2026-11-12
- DOI
- https://doi.org/10.33590/emjdermatol/t20t7qbi
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00